ロード中...
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment outcome. Here, we examined whether a miRNA signature can be defined for the a priori identification of patients with particularly poor prognosis. FFPE sections from 36 GBM patients along with overall...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216759/ https://ncbi.nlm.nih.gov/pubmed/27302927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9945 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|